Skip to main content
Clinical Trials/CTRI/2021/04/033066
CTRI/2021/04/033066
Not yet recruiting
未知

First trimester maternal serum glycosylated fibronectin as a predictor of preeclampsia-A Descriptive Observational Study

Dr Vomica Kewalramani0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O149- Unspecified pre-eclampsia
Sponsor
Dr Vomica Kewalramani
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Vomica Kewalramani

Eligibility Criteria

Inclusion Criteria

  • Multigravida with Gestational age\-11\-14 weeks with singleton pregnancy

Exclusion Criteria

  • K/c/o pre eclampsia
  • K/c/o gestational hypertension
  • K/c/o renal disease
  • K/c/o liver disease

Outcomes

Primary Outcomes

Not specified

Similar Trials